Devyser Diagnostics AB has been awarded a tender for Devyser?s CFTR fragment analysis products, that are used for screening and confirmation of cystic fibrosis. The tender with the University Hospital in Verona is valid for a period of twelve months. Indicative order value is estimated to amount to approximately SEK 1.5 million .
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
104.5 SEK | +2.96% | +1.95% | +32.95% |
May. 27 | Devyser Wins Tender for Thalassemia in Italy | CI |
May. 14 | Devyser Diagnostics AB Appoints Thomas Eklund as Member of the Board of Directors | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.95% | 162M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- DVYSR Stock
- News Devyser Diagnostics AB
- Devyser Diagnostics AB Wins Tender for Cystic Fibrosis in Italy